Atrix Antibacterial Wash

Description

Atrix™ Antibacterial Wash is manufactured in the USA by PureTek Corporation, located in Panorama City, CA 91402. For inquiries, a toll-free contact number is available at 1-877-921-7873.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively dries and clears acne pimples, acne blemishes, whiteheads, and blackheads. Additionally, it helps prevent the development of new acne pimples, acne blemishes, whiteheads, and blackheads.

There are no teratogenic effects associated with this drug. Furthermore, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to instruct patients to cleanse the affected area twice daily. The cleansing process begins with wetting the face. Patients should then apply the product to their hands, add water, and work it into a lather. A gentle massage of the face is recommended to ensure even distribution of the product. Following this, the face should be rinsed thoroughly with water and patted dry.

In cases where patients experience bothersome dryness or peeling, it is recommended to reduce the frequency of application to once daily or every other day. This product should be used under the direction of a medical practitioner to ensure appropriate use and monitoring of the patient's response to treatment.

Contraindications

Use is contraindicated in patients who experience skin irritation or worsening of skin conditions. Concurrent use with other topical acne medications is also contraindicated due to the potential for increased skin irritation and dryness.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid simultaneous use of this product with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event of irritation, it is recommended that patients discontinue use of all topical acne treatments and consult with a healthcare provider.

In case of accidental contact with the eyes, patients should rinse the affected area immediately with water to mitigate potential irritation.

Patients should be instructed to stop using the product and seek medical advice if they experience skin irritation that persists or worsens.

In the event of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience adverse reactions, primarily skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be utilized at a time to minimize the risk of irritation.

In the event of skin irritation, patients are instructed to discontinue use and consult a healthcare professional, especially if the irritation worsens. Additionally, if the product comes into contact with the eyes, it should be rinsed immediately with water to prevent further complications.

This product is for external use only. Care should be taken to keep it out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Atrix Antibacterial Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored to ensure the medication is kept out of reach to prevent accidental ingestion. In the event of swallowing the medication, immediate medical assistance or contact with a Poison Control Center is advised. The use of this medication in pediatric populations should only occur under the guidance of a qualified medical practitioner to ensure safety and efficacy.

Geriatric Use

Elderly patients may not have specific dosage adjustments, safety concerns, or special precautions outlined in the drug insert for Atrix Antibacterial Wash. As such, healthcare providers should exercise caution when prescribing this product to geriatric patients, given the absence of targeted clinical findings or recommendations for this population.

It is advisable for healthcare providers to monitor elderly patients closely for any potential adverse effects or changes in efficacy, considering the general physiological changes associated with aging that may affect drug metabolism and response.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. Pregnant women should avoid using this product unless directed by a healthcare provider. It is essential for healthcare professionals to weigh the potential risks against the benefits when considering treatment options for pregnant patients.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to be aware of the potential for skin irritation; they should be instructed to discontinue use and consult a doctor if any skin irritation occurs or worsens.

Patients should also be informed that the likelihood of skin irritation and dryness may increase if they are using another topical acne medication concurrently. Therefore, it is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

In the event that the product comes into contact with the eyes, patients should be instructed to rinse the area immediately with water to alleviate any discomfort.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled room temperature, specifically between 20° to 25°C (68° to 77°F), in accordance with USP guidelines.

To ensure the integrity of the product, it must be protected from freezing and should be kept away from excessive heat. Proper handling and storage conditions are crucial for maintaining the product's efficacy and safety.

Additional Clinical Information

Patients should cleanse their face twice a day using the following method: wet the face, apply the product to hands, add water to create a lather, and gently massage the face. It is important to rinse thoroughly and pat dry. If bothersome dryness or peeling occurs, patients are advised to reduce the frequency of application to once a day or every other day.

Clinicians should counsel patients to use the product under medical supervision. They should be informed that skin irritation and dryness may be exacerbated by concurrent use of other topical acne medications; therefore, only one topical acne medication should be used at a time. Patients should rinse the product from their eyes immediately if contact occurs and are advised to discontinue use and consult a doctor if skin irritation develops or worsens.

Drug Information (PDF)

This file contains official product information for Atrix Antibacterial Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)